These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35292576

  • 21. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J, Basáñez MG, O'Hanlon SJ, Tekle AH, Wanji S, Zouré HG, Rebollo MP, Pullan RL.
    Parasit Vectors; 2018 Jan 31; 11(1):70. PubMed ID: 29382363
    [Abstract] [Full Text] [Related]

  • 22. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP, Rajendran R, Mani TR, Dash AP, Tyagi BK.
    Lancet Infect Dis; 2006 Mar 31; 6(3):125-6. PubMed ID: 16500593
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P, Kuttiatt VS, Krishnamoorthy K, Subramanian S, Srividya A, Raju HKK, Rahi M, Somani RK, Suryaprakash MK, Dwivedi GP, Weil GJ.
    PLoS Negl Trop Dis; 2021 Feb 31; 15(2):e0009069. PubMed ID: 33591979
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
    Sabesan S, Krishnamoorthy K, Hoti SL, Subramanian S, Srividya A, Roy N, Jain T, Kumar A, Rahi M.
    Indian J Med Res; 2022 Mar 31; 155(3&4):347-355. PubMed ID: 36124509
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Albendazole for lymphatic filariasis.
    Critchley J, Addiss D, Gamble C, Garner P, Gelband H, Ejere H, International Filariasis Review Group.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD003753. PubMed ID: 16235339
    [Abstract] [Full Text] [Related]

  • 35. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG.
    J Vector Borne Dis; 2010 Mar 19; 47(1):61-4. PubMed ID: 20231778
    [No Abstract] [Full Text] [Related]

  • 36. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May 16; 78(20):171-9. PubMed ID: 12808788
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
    Rajendran R, Mani TR, Munirathinam A, Sunish IP, Abdullah SM, Augustin DJ, Satyanarayana K.
    Trans R Soc Trop Med Hyg; 2003 May 16; 97(3):355-9. PubMed ID: 15228259
    [Abstract] [Full Text] [Related]

  • 39. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P, Supali T, Maizels RM.
    Trends Parasitol; 2004 Aug 16; 20(8):351-5. PubMed ID: 15246315
    [Abstract] [Full Text] [Related]

  • 40. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct 01; 79(40):358-65. PubMed ID: 15631012
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.